New pain block could cut opioid use after gynecologic cancer surgery
NCT ID NCT07458295
First seen Mar 11, 2026 · Last updated May 19, 2026 · Updated 10 times
Summary
This study tests whether a special long-acting numbing medicine (liposomal bupivacaine) injected into the abdominal wall can provide better pain relief for up to 72 hours after laparoscopic gynecologic cancer surgery. About 110 women aged 18-64 will be randomly assigned to receive either the long-acting painkiller plus standard numbing medicine or standard care alone. The goal is to see if this approach reduces the need for strong opioid painkillers and improves recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LAPAROSCOPIC SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital
RECRUITINGBeijing, Beijing Municipality, 100070, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.